Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Restraint, Physical × CNS × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3 Sarcoma 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Neuroblastoma 1 Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 37 Temozolomide 33 Specimen Handling 27 Radiotherapy 24 Biopsy 15 Radiosurgery 13 Cyclophosphamide 12 pembrolizumab 10 Radiation 10 Nivolumab 9 Bevacizumab 8 Ipilimumab 7 abemaciclib 6 AZD 6244 6 trastuzumab deruxtecan 5 dinutuximab 5 X-Rays 5 trametinib 4 sargramostim 4 olaparib 4 fludarabine 4 cabozantinib 4 Vincristine 4 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Eflornithine 4 Colony-Stimulating Factors 4 tovorafenib 3 etoposide phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡